Compound ID | 1545
CPZEN-45 analog 5
Class: Mycolyl arabinogalactan biosynthesis inhibitor
| Details of activity: | Novel antituberculosis drug. Also active against M. intracellulare |
| Institute where first reported: | Institute of Microbial Chemistry, Kamiosaki, Shinagawa-ku, Tokyo, Japan |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-019-0225-5 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.